| Product Code: ETC7905734 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Bacteriophages Therapy Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Bacteriophages Therapy Market - Industry Life Cycle |
3.4 Latvia Bacteriophages Therapy Market - Porter's Five Forces |
3.5 Latvia Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 Latvia Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Latvia Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Latvia Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections |
4.2.2 Growing adoption of bacteriophages therapy as an alternative to antibiotics |
4.2.3 Rising investment in research and development of bacteriophage-based products |
4.3 Market Restraints |
4.3.1 Limited awareness among healthcare professionals and patients about bacteriophages therapy |
4.3.2 Regulatory challenges in the approval and commercialization of bacteriophage products |
4.3.3 Lack of standardized guidelines for the use of bacteriophages in clinical settings |
5 Latvia Bacteriophages Therapy Market Trends |
6 Latvia Bacteriophages Therapy Market, By Types |
6.1 Latvia Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 Latvia Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 Latvia Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 Latvia Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 Latvia Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 Latvia Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 Latvia Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 Latvia Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Latvia Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Latvia Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Latvia Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 Latvia Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 Latvia Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 Latvia Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 Latvia Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 Latvia Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Latvia Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Latvia Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 Latvia Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Latvia Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Latvia Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Latvia Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Latvia Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Latvia Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 Latvia Bacteriophages Therapy Market Export to Major Countries |
7.2 Latvia Bacteriophages Therapy Market Imports from Major Countries |
8 Latvia Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on bacteriophages therapy |
8.2 Adoption rate of bacteriophages therapy in healthcare facilities |
8.3 Success rate of bacteriophage treatments in patients |
8.4 Investment in companies developing bacteriophage-based products |
8.5 Number of partnerships and collaborations in the bacteriophages therapy market |
9 Latvia Bacteriophages Therapy Market - Opportunity Assessment |
9.1 Latvia Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 Latvia Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Latvia Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Latvia Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Bacteriophages Therapy Market - Competitive Landscape |
10.1 Latvia Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 Latvia Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here